QSS
CTIC

Quantitative Systematic Strategies’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Quantitative Systematic Strategies’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-25,686
Closed -$64K – 440
2021
Q2 		$64K Sell
25,686
-323
-1% -$774 0.02% 444
2021
Q1 		$76K Buy
26,009
+5,011
+24% +$16.4K 0.01% 589
2020
Q4 		$68K Buy
+20,998
New +$69.8K 0.01% 589

Other funds holding CTIC

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Quantitative Systematic Strategies's CTIC Position: Q3 2021 in Review

Quantitative Systematic Strategies sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q3 2021, closing a stake of 25,686 shares — an estimated $64K sold.

Quantitative Systematic Strategies first reported a position in CTIC in Q4 2020 and held it in 3 quarters. The position peaked at $76K in Q1 2021. 56 funds tracked by Wall St. Rank hold CTIC as of Q3 2021.

  • Quantitative Systematic Strategies reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q3 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 25,686 CTI BioPharma Corp. (DE) Common Stock shares in Q3 2021, an estimated $64K.
  • Quantitative Systematic Strategies first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q4 2020 and held it in 3 quarters.
  • Quantitative Systematic Strategies's CTI BioPharma Corp. (DE) Common Stock position peaked at $76K in Q1 2021.
  • 56 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q3 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q3 2021, filed 16 Nov 2021.